The European NAFLD Registry
Research type
Research Study
Full title
The European NAFLD Registry
IRAS ID
229678
Contact name
Quentin Anstee
Contact email
Duration of Study in the UK
4 years, 11 months, 31 days
Research summary
Aim: To validate a range of non-invasive biomarkers that will grade/stage liver disease in patients with NAFLD.
Plan: Recruit patients undergoing clinically indicated liver biopsies for NAFLD, collect additional blood samples, urine samples and stool samples for research use. Administer questionnaires (dietary, exercise, wellbeing/symptoms). Collect data from routine investigations from medical notes. Follow patients longitudinally at 1-year intervals, collecting additional samples, etc.
A subset of patients participating in the European NAFLD Registry may opt-in to a nested imaging study using ultrasound and MRI (i.e. NO study-related x-ray exposure or administration of contrast agents). This imaging study will involve a separate IRAS application and informed consent but data may be shared with the current project.
REC name
North East - Tyne & Wear South Research Ethics Committee
REC reference
18/NE/0182
Date of REC Opinion
2 Jul 2018
REC opinion
Favourable Opinion